(no text — see the shared post below)
Berberine 500 mg twice daily lowered ApoB in two trials; CVD prevention unproven
A shared summary says two randomized trials of 500 mg berberine twice daily reduced ApoB, with a reduction nearly three times greater in women, though across separate trials. A newer study of 84 men identified a 'Berberine Signature' of 92 proteins linked to about 13% lower odds of ischemic heart disease in UK Biobank, but those participants were not necessarily taking berberine, so it does not prove prevention.


